Literature DB >> 11091846

Evolutionary aspects of oncogenic herpesviruses.

J Nicholas1.   

Abstract

Several of the gamma-herpesviruses are known to have cellular transforming and oncogenic properties. The genomes of eight distinct gamma-herpesviruses have been sequenced, and the resulting database of information has enabled the identification of genetic similarities and differences between evolutionarily closely related and distant viruses of the subfamily and between the gamma-herpesviruses and other members of the herpesvirus family. The recognition of coincident loci of genetic divergence between individual gamma-herpesviruses and the identification of novel genes and cellular gene homologues in these genomic regions has delineated a subset of genes that are likely to contribute to the unique biological properties of these viruses. These genes, together with gamma-herpesvirus conserved genes not found in viruses outside the family, might be responsible for virus specific pathogenicity and pathogenic effects, such as viral associated neoplasia, characteristic of the subfamily. The presence of the gamma-herpesvirus major divergent genomic loci and the apparent increased mutational frequencies of homologous genes (where they occur) within these regions, indicates that these loci possess particular features that drive genetic divergence. Whatever the mechanisms underlying this phenomenon, it potentially provides the basis for the relatively rapid adaptation and evolution of gamma-herpesviruses and the diversity of biological and pathogenic properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091846      PMCID: PMC1186975          DOI: 10.1136/mp.53.5.222

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  173 in total

Review 1.  The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.

Authors:  U A Gompels; J Nicholas; G Lawrence; M Jones; B J Thomson; M E Martin; S Efstathiou; M Craxton; H A Macaulay
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

2.  Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses.

Authors:  D J McGeoch; S Cook; A Dolan; F E Jamieson; E A Telford
Journal:  J Mol Biol       Date:  1995-03-31       Impact factor: 5.469

3.  Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.

Authors:  C L Miller; A L Burkhardt; J H Lee; B Stealey; R Longnecker; J B Bolen; E Kieff
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

5.  Characterization of the major locus of immediate-early genes of rat cytomegalovirus.

Authors:  G R Sandford; K Ho; W H Burns
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.

Authors:  P D Ling; J J Ryon; S D Hayward
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.

Authors:  J J Ryon; E D Fixman; C Houchens; J Zong; P M Lieberman; Y N Chang; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

Authors:  J J Hsieh; S D Hayward
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

9.  The DNA sequence of equine herpesvirus 2.

Authors:  E A Telford; M S Watson; H C Aird; J Perry; A J Davison
Journal:  J Mol Biol       Date:  1995-06-09       Impact factor: 5.469

10.  The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity.

Authors:  W L Fodor; S A Rollins; S Bianco-Caron; R P Rother; E R Guilmette; W V Burton; J C Albrecht; B Fleckenstein; S P Squinto
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  7 in total

1.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

2.  The Current State of Vaccine Development for Ocular HSV-1 Infection.

Authors:  D J Royer; A Cohen; Djj Carr
Journal:  Expert Rev Ophthalmol       Date:  2015-04-01

Review 3.  Gamma herpesviruses: pathogenesis of infection and cell signaling.

Authors:  J Rajcáni; M Kúdelová
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

4.  Prevalence, Geographic Distribution, Risk Factors and Co-Infections of Feline Gammaherpesvirus Infections in Domestic Cats in Switzerland.

Authors:  Marilisa Novacco; Neda Ranjbar Kohan; Martina Stirn; Marina L Meli; Adrian Alberto Díaz-Sánchez; Felicitas S Boretti; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2019-08-06       Impact factor: 5.048

5.  A novel strain of cynomolgus macaque cytomegalovirus: implications for host-virus co-evolution.

Authors:  Justen N Hoffman Russell; Angie K Marsh; David O Willer; Aruna P N Ambagala; Misko Dzamba; Jacqueline K Chan; Richard Pilon; Jocelyn Fournier; Michael Brudno; Joseph M Antony; Paul Sandstrom; Ben J Evans; Kelly S MacDonald
Journal:  BMC Genomics       Date:  2016-04-05       Impact factor: 3.969

Review 6.  Adaptation by copy number variation in monopartite viruses.

Authors:  Avraham Bayer; Greg Brennan; Adam P Geballe
Journal:  Curr Opin Virol       Date:  2018-07-14       Impact factor: 7.090

7.  Contrasting roles for G-quadruplexes in regulating human Bcl-2 and virus homologues KSHV KS-Bcl-2 and EBV BHRF1.

Authors:  Shivani Kumar; Chitteti Ramamurthy; Divya Choudhary; Aashika Sekar; Anupam Patra; Neel Sarovar Bhavesh; Perumal Vivekanandan
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.